摘要
肝动脉栓塞化疗(TACE)结合了栓塞和化疗两种治疗方法.尽管TACE的临床疗效显著,但单独采用TACE仍无法治愈肝癌.栓塞难以完全、侧支循环建立和新生血管等原因大大影响其远期疗效.因此,TACE疗效的提高有赖于综合治疗.为此,本文从栓塞剂、化疗药物、联合治疗等方面就TACE在肝癌治疗中的应用现状及进展做一综述.
Transarterial chemoembolization (TACE) combined the embolization with chemotherapy,whose efficacy has been verified in the treatment of hepatocellular carcinoma.Factors like the incomplete embolism,the formation of collateral circulation,neoangiogenesis and the like greatly weaken the clinical efficacy of TACE in the long term.Thus,the improvement of TACE efficacy depends on the comprehensive treatment.This paper reviewed the present application status and the progress on the treatment of hepatocellular carcinoma with TACE.
出处
《中华肝胆外科杂志》
CAS
CSCD
北大核心
2016年第2期137-141,共5页
Chinese Journal of Hepatobiliary Surgery
基金
国家高新技术研究计划,National High Technology Research and Development Program of China
关键词
肝动脉栓塞化疗
肝癌
栓塞剂
化疗药
综合治疗
Transarterial chemoembolization
Hepatocellular carcinoma
Embolic agent
Chemotherapeutic drugs
Comprehensive treatment